SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-035037
Filing Date
2023-12-21
Accepted
2023-12-21 09:25:23
Documents
17
Period of Report
2023-12-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbla20231220c_8k.htm   iXBRL 8-K 50949
2 EXHIBIT 4.1 ex_609199.htm EX-4.1 131140
3 EXHIBIT 10.1 ex_609200.htm EX-10.1 62544
4 EXHIBIT 99.1 ex_609213.htm EX-99.1 16983
9 ex_609213img001.jpg GRAPHIC 5243
  Complete submission text file 0001437749-23-035037.txt   462596

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA pbla-20231221.xsd EX-101.SCH 3410
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20231221_def.xml EX-101.DEF 11425
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20231221_lab.xml EX-101.LAB 15311
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20231221_pre.xml EX-101.PRE 11585
11 EXTRACTED XBRL INSTANCE DOCUMENT pbla20231220c_8k_htm.xml XML 2564
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 231503035
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)